Your search for bevacizumab returned 12 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Uncategorized remove

Your search for bevacizumab returned 12 results

Sort Results:

Relevant Recent

After reports surfaced of five intraocular infections at a physician’s office, Clinical Specialties is undertaking a voluntary recall of Avastin unit dose syringes. The sterile syringes were being used solely for an off-label indication by an ophthalmologist for macular degeneration.

The FDA has confirmed that a counterfeit version of Roche’s Altuzan 400mg/16mL (bevacizumab), an injectable cancer medication, found in the US contains no active ingredient.

The FDA is warning healthcare professional about a counterfeit version of Avastin 400mg/16mL, which may have been purchased and used by some medical practices in the U.S.


Genentech announced that during a FDA hearing, the FDA’s Oncologic Drugs Advisory Committee (ODAC) recommended that the FDA withdraw its approval of Avastin (bevacizumab) in combination with paclitaxel chemotherapy for previously untreated, first-line HER2-negative metastatic breast cancer.